The Division of Insurance (DOI) has once again issued a bulletin reminding health insurance companies that they have a responsibility during the pandemic to ease up on their administrative billing.
Bulletin 2020-25 issued on July 29 concerns the recent rapid expansion of polymerase chain reaction (PCR) and antigen testing for COVID-19, and the resultant delays in processing the tests. DOI wrote that it is aware that new laboratories are becoming available to process tests but have not yet developed administrative systems to properly bill insurers for the tests as they are conducted.
“In order to meet the public health need, carriers are expected to take steps that will permit covered tests to be done by such laboratories and for the related bills to be processed for the laboratories,” DOI wrote.
The division also said that while health insurers may currently have contracts that prohibit “pass-through” billing – that is, when a hospital or health center bills an insurer for a test that is sent out to an independent laboratory – DOI now expects those prohibitions to end.
“From the date that Bulletin 2020-25 is issued and for the duration of the public health emergency, the Division expects carriers to relax these provisions for the processing of PCR and antigen tests,” DOI wrote. Insurers are also expected to pay the provider the same rate for the test that they would pay the external laboratory, without adding on an additional charge for processing the claim.
Throughout the pandemic, DOI has issued numerous bulletins stressing the need for insurers to stop conducting business as usual.